Silberman David
Insider Reports History
- Location
- Jerusalem, Israel
- Signature
- /s/ Silberman David
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Silberman David:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Chief Financial Officer | Common Stock | 366,500 | $809,965 | $2.21 | 04 Jan 2024 | Direct |
| COMPUGEN LTD | Chief Financial Officer | Ordinary Shares | 35,500 | $62,835 | $1.77 | 18 Mar 2026 | Direct |
Insider Reports Filed by Silberman David
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NSRX | Nasus Pharma Ltd | 18 Mar 2026 | 0 | $0 | 3 | Director | 27 Mar 2026, 20:56 |
| CGEN | COMPUGEN LTD | 18 Mar 2026 | 0 | $0 | 3 | Chief Financial Officer | 18 Mar 2026, 06:27 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 04 Jan 2024 | 1 | $0 | 4 | Chief Financial Officer | 08 Jan 2024, 16:39 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 26 May 2023 | 1 | $0 | 4 | Chief Financial Officer | 31 May 2023, 17:10 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 17 Apr 2023 | 1 | $0 | 4 | Chief Financial Officer | 20 Apr 2023, 06:00 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 28 Jul 2022 | 1 | $0 | 4 | Chief Financial Officer | 01 Aug 2022, 20:00 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 03 Jan 2022 | 2 | $0 | 4 | Chief Financial Officer | 05 Jan 2022, 19:32 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 01 Sep 2021 | 2 | $0 | 4 | Chief Financial Officer | 02 Sep 2021, 16:48 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 05 Jul 2021 | 0 | $0 | 3 | Chief Financial Officer | 08 Jul 2021, 16:30 |